Bayer AG
0
0
0%

Financials

Income statement

Fundamentals currency is EUR
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.7T 4.1T 5.3T 4.5T
Cost of revenue 1.7T 1.7T 2.2T 2.2T
Gross profit 2.1T 2.5T 3.1T 2.3T
Operating expense
Research & development 577.9B 543.1B 562.4B 665.4B
Selling general and admin 1.3T 1.4T 1.4T 1.7T
Other operating expenses 505.0B 814.3B 319.8B -1.5T
Operating income -209.5B 5.0B 896.5B 1.4T
Non operating interest income
Income 50.1B 35.5B 44.0B
Expense 293.9B 150.4B 182.5B 148.5B
Other income expense
Pretax income -447.9B -164.3B 705.9B -185.6B
Tax provision -77.9B -91.0B 202.9B -59.0B
Net income -369.9B -73.3B 503.0B -126.5B
Basic EPS -1.0 -0.2 1.3
Diluted EPS -1.0 -0.2 1.3
Basic average shares 379.0B 379.0B 379.0B
Diluted average shares 379.0B 379.0B 379.0B
EBITDA 233.8B 91.0B 1.3T 644.6B
Net income from continuing op. -369.9B -73.3B 503.0B -126.5B
Minority interests -1.5B -3.5B -1.9B -2.7B
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 7 minutes

09:52
00:00
09:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Budapest timezone (CET, UTC+01:00).